Informações:
Falhas:
ID
14536
Descrição
Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi); ODM derived from: https://clinicaltrials.gov/show/NCT00702247
Link
https://clinicaltrials.gov/show/NCT00702247
Palavras-chave
Versões (1)
- 19/04/2016 19/04/2016 -
Transferido a
19 de abril de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Multiple Myeloma NCT00702247
Eligibility Multiple Myeloma NCT00702247
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT00702247
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Durie-salmon stage
Item
durie-salmon stage iia-iiib multiple myeloma
boolean
C0278723 (UMLS CUI [1])
C0278724 (UMLS CUI [2])
C0278724 (UMLS CUI [2])
Age
Item
age > 18 and ≤ 65 years
boolean
C0001779 (UMLS CUI [1])
Untreated myeloma
Item
previously untreated myeloma
boolean
C0026764 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,2])
Sibling
Item
presence of a sibling (potential donor)
boolean
C0037047 (UMLS CUI [1])
Bilirubin, alat and asat
Item
bilirubins < twice normal;alat and asat < four times normal
boolean
C1278039 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
Left ventricular ejection fraction
Item
left ventricular ejection fraction > 40%
boolean
C0428772 (UMLS CUI [1])
Creatinine clearance
Item
creatinine clearances > 40 ml/min
boolean
C0373595 (UMLS CUI [1])
Dlco, continuous oxygen supplementation
Item
pulmonary dysfunction with diffusing capacity for carbon monoxide (dlco) > 40% and/or need for continuous oxygen supplementation
boolean
C1516251 (UMLS CUI [1])
C4039841 (UMLS CUI [2])
C4039841 (UMLS CUI [2])
Karnofsky performance status
Item
karnofsky performance status > 60%
boolean
C0206065 (UMLS CUI [1])
Informed consent
Item
patients must give written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age > 65 years
boolean
C0001779 (UMLS CUI [1])
Treated myeloma
Item
previously treated myeloma
boolean
C0026764 (UMLS CUI [1,1])
C0332154 (UMLS CUI [1,2])
C0332154 (UMLS CUI [1,2])
Sibling
Item
absence of a sibling (genetic randomisation cannot be applied)
boolean
C0037047 (UMLS CUI [1])
Karnofsky performance status
Item
karnofsky performance status score < 60%
boolean
C0206065 (UMLS CUI [1])
HIV-infection
Item
hiv-infection
boolean
C0019693 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Contraception
Item
refusal to use contraceptive techniques during and for 12 months following treatment
boolean
C0700589 (UMLS CUI [1])
Unable to informed consent
Item
patients unable to give written informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])
Informed consent: specification
Item
ps. informed consent is obtained from each patient according to the institutional review boards of the participating centers. the study is conducted according to the declaration of helsinki.
boolean
C0021430 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])